Colorectal cancer is the second most frequently diagnosed cancer in Spain. Cancer treatment and outcomes can be influenced by tumor characteristics, patient general health status and comorbidities. Numerous studies have analyzed the influence of comorbidity on cancer outcomes, but limited information is available regarding the frequency and distribution of comorbidities in colorectal cancer patients, particularly elderly ones, in the Spanish population.
dementia and the high proportion of older patients not being offered surgical treatment are significant findings that require policy actions.
Introduction
Cancer accounted for 9.6 million deaths globally in 2018, and was the second most common cause of death in the world [1] . Colorectal cancer (CRC) is the most frequently diagnosed cancer in Spain, with 37,172 newly diagnosed cases in 2018 [2] . Despite the high prevalence of CRC in the elderly, the inclusion of this cohort in clinical trials is disproportionately low [3] . In addition to clinical and pathological characteristics of the tumor, general health status and comorbidities of patients also influence cancer treatment and outcomes.
Comorbidity describes the existence of a long-term health condition or disorder in the presence of a primary disease of interest, such as cancer [4] , whereas multimorbidity refers to the existence of more than one comorbid condition [5] . Comorbidity and multimorbidity are increasingly seen as a problem of the elderly, but have also been reported as occurring more often and at a younger age in patients of lower socioeconomic status [6, 7] . The presence of comorbidities can influence treatment options, and therefore should be thoroughly evaluated when studying prognosis, outcomes, and mortality in cancer patients. Despite the coexistence of health conditions being commonplace, the guidelines and delivery of care appear to be focused on single disease management [8, 9] . However, effective management of comorbid conditions is important in maintaining patients' optimal health status, as the presence of one could contribute to the development of another [10] , and decisions regarding cancer treatment require the consideration of patients' comorbidities [11, 12] . Furthermore, post-operative complications have been reported as higher in patients with comorbidity [13] , and certain comorbid conditions have been linked to adverse outcomes following surgery for cancer [14] .
As noted above, there is consistent evidence on the influence of comorbidities on cancer outcomes, but little is known about them in CRC patients. Thus, we aimed to describe the frequency and distribution of comorbidities and multimorbidity, as well as their associated risk factors in the cohort of all CRC incident cases diagnosed in Granada and Girona (Spain) in 2011.
Materials and methods

Study design, participants, data, and setting
We conducted a population-based cohort study including all CRC incident cases (C18-C21), according to the International Classification of Diseases for Oncology, 3 rd Edition, (ICD-O-3), diagnosed in 2011 and followed up until December 31, 2016 from two population-based Spanish cancer registries (Girona and Granada). Data were obtained from hospital medical records following a detailed protocol from the European High Resolution studies collaboration (TRANSCAN-HIGHCARE project within ERA-Net) [15] . We recorded information regarding the cancer stage at diagnosis (TNM staging system, 7 th edition), cancer diagnostic exams, tumor morphology, cancer treatment, patients' comorbidities, performance status, and vital status. All recorded comorbidities were extracted 6 months before the index cancer was diagnosed, based on a standardized protocol published elsewhere [16] . All information was classified as either patient, tumor, or healthcare factors. Our study proposal (CP17/00206) was titled "Comorbidities and Associated Risk Factors among Colorectal Cancer Patients in Spain" (CoMCoR), and approved by an internal review board and an ethical review committee with internal number 0072-N-18.
Variables related to the patient's characteristics
We recorded patient's age, sex, smoking status, body mass index (BMI), performance status, comorbidities, and multimorbidity. Age at diagnosis was categorized into four age groups: <55, 55-64, 65-74, and ≥ 75 years. Smoking status was categorized as current, previous, and never smoker. BMI was categorized as normal (<25.0 kg/m 2 ), overweight (≥25.0 kg/m 2 and <30 kg/m 2 ), and obese (≥30 kg/m 2 ). Patients' performance status was ascertained using the Eastern Cooperative Oncology Group (ECOG) scale and categorized as normal (0); restricted but able to carry out light work (1); restricted, unable to work but capable of self-care (2); restricted, capable of limited self-care (3); and disabled (4) [17] . Comorbidities were classified based on the Royal College of Surgeons modified Charlson score that reduces the number of comorbidities to 12 (myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease (COPD), rheumatic disease, liver disease, diabetes mellitus, hemiplegia/paraplegia, renal disease and AIDS/HIV), removing some categories such as peptic ulcer disease (since it is not considered a chronic disease anymore), and grouping diseases together (e.g., diabetes mellitus codes with or without complications are grouped into one category). Furthermore, the score drops the weighting of comorbidities, and instead categorizes the number of comorbidities in three categories: 0, 1, and ≥ 2 as a multimorbidity indicator [18] .
Variables related to tumor characteristics
We recorded the tumor topography, morphology, grade of differentiation, and stage at diagnosis. The final stage variable was defined as the combination of clinical and pathological TNM stages and categorized into five groups, based on the 7 th edition of the TNM manual.
Topography, grade of differentiation, and morphology were coded according to ICD-O-3.
Variables related to healthcare provision factors
We recorded the type of hospital admission, surgery, type of surgery, and time to surgery. Type of hospital admission indicated whether cancer patients had an emergency or planned admission. The type of surgery was dichotomized as major or minor, and the time to surgery was noted as the number of days from the date of cancer diagnosis to the date patients had the surgical intervention and categorized into five groups (0, 1 to <14, 14 to 30, 31 to 59 and ≥ 60 days). Emergency surgery was defined as surgery offered on the same day of an emergency hospital admission.
Statistical analysis
First, we calculated the prevalence of each of the 12 different comorbidities for the cohort of CRC patients. Then, we calculated the frequency and distribution of comorbidities by patient, tumor and healthcare factors using counts and proportions. The Chi-square, Fisher's exact, and score tests were used for statistical inference. We assumed missing data, in a completely at random pattern, and thus performed a complete case analysis. Afterward, we computed unadjusted, sex-adjusted, and age-adjusted comorbidity prevalence ratios (PRs) with 95% confidence intervals (CIs) by patient, tumor, and healthcare factors. Generalized linear models with Poisson distribution and log link were fitted for the five most common comorbidities plus dementia. We included the specific comorbidity indicator as the dependent variable; patient, tumor, and health care factors were the independent variables [19] . To describe the risk factors associated with the presence of multimorbidity (≥2 chronic conditions vs. non-comorbidities) we fitted a multinomial logistic regression model using the Royal College of Surgeons modified Charlson score as the dependent variable, with patient, tumor, and health care factors as independent variables. Risk factors associated with multimorbidity were evaluated using noncomorbidity as the reference category. Then, we derived unadjusted, age-adjusted, and sexadjusted risk ratios (ARRs) with 95% CIs. Finally, we developed an open source web application using advanced visualization tools (radar plots, heat maps and forest plots) [20] to reduce the dimensionality of the data and display the results for the ten most common comorbidities plus dementia, available at http://watzilei.com/shiny/CoMCoR/. Furthermore, we created a GitHub repository where the code used to develop the analysis and the web application can be accessed for reproducibility (https://github.com/migariane/CoMCoR). Table 1 shows the distribution of patient, tumor, and healthcare characteristics from the cohort of colorectal cancer patients under study. More than half (59%) of colorectal cancer patients had one or more comorbidities 6 months before cancer diagnosis, and 30% had multimorbidity. Men represented 61% of the cohort, 67% of patients were age >65 years, 12% had a restricted performance status, slightly more than half of them were previous or current smokers (52%), and 49% were overweight or obese. The prevalence of the different tumor locations was 34% in the right colon, 32% in the left colon, and 33% in the rectum. The differentiation of the tumor was mostly grade two (56%); however, 19% of the tumors were not graded. Only 16% of colorectal cancer patients had a stage I tumor at diagnosis, while more than 50% of the cases were identified as stage III/IV. Six percent of patients had missing stage information. The type of hospital admission was principally planned (65%), and almost one out of five patients were admitted after visiting the hospital emergency department. Surgery was performed in 83% of the patients, and the most frequent type of surgery was major surgery (77%). The time to surgery exceeded 60 days for 26% of the patients. Sixteen percent of the colorectal cancer cases had emergency surgery (Table 1) . Table S1 shows the prevalence of comorbidities among CRC patients at least 6 months before the cancer diagnosis, ordered by frequency. Diabetes mellitus, COPD, and congestive heart failure were the most common comorbidities among CRC patients (24%, 17%, and 15%, respectively). Figure 1 shows the distribution of the prevalence of the topten comorbidities by sex. The most common comorbidity among men was COPD and rheumatologic disease and dementia among women. Table 2 shows the frequency and crude prevalence ratio of comorbidities for the five most common comorbidities plus dementia by tumor, patient, and health. Supporting information Table S2 shows sex-adjusted and age-adjusted comorbidity prevalence ratios by tumor, patient, and health care factors. The complete distribution of comorbidities is provided as supporting information ( Supplementary Tables S3, S4 , and S5).
Results
Patient and tumor characteristics
Supporting information
Distribution and frequency of comorbidities by tumor characteristics
The pattern of comorbidities by sex shows a high prevalence of COPD among male colorectal cancer patients (79%), while almost 60% of patients with dementia or rheumatologic disease were female. There was a frequency gradient of comorbidities by age, with dementia (75%), congestive heart failure (64%), and renal disease (46%) as the most common comorbidities among the elderly. Patients' performance status varied among comorbidities as well. Ninety-two percent of liver disease patients and 80% of diabetes patients had ECOG performance score 0 or 1, in contrast to only 53% of dementia and 30% of congestive heart failure patients. There was strong evidence supporting a significant trend of comorbidity prevalence across the levels of performance status for the five most common comorbidities plus dementia. Furthermore, COPD, diabetes, and dementia were more frequently associated with smoking (current and previous): 68%, 53%, and 36%, respectively. Adjusted PRs (APRs) comparing current smoker vs. never smoker in COPD, diabetes, and dementia were 3.1 (95% CI: 1.9-5.0), 1.3 (95% CI: 0.8-2.0), and 1.8 (95% CI: 0.6-5.2), respectively. Overweight and obesity 
Distribution and frequency of comorbidities by tumor's characteristics
The most prevalent comorbidity in right colorectal cancer patients was dementia (44%) and rheumatic disease for rectal cancer patients (38%). Regarding the grade of differentiation, the most common grade for all the different comorbidities was grade two (moderately differentiated). However, diabetes had the highest proportion of grade three (30%) and an APR of 1.4 (95% CI: 0.9-2.0) comparing grades three-four vs. one. Overall, all comorbidities had approximately 55% of cancer cases diagnosed at stages III or IV. Patients with COPD showed the lowest frequency of stage IV (22%). CRC patients with dementia had a 30% higher prevalence of advanced cancer diagnosis i.e. APR 1.3; 95% CI: 0.5-3.2 comparing stage IV vs I (Tables 2 and S2 ).
Distribution and frequency of comorbidities by healthcare characteristics
Patients with dementia showed the highest prevalence of emergency hospital admission after CRC diagnosis (33%) with an APR comparing planned vs. emergency admission of 1.6 (95% CI: 1.1-2.2). Despite the emergency admission, dementia was the comorbidity with the 1 3 highest prevalence of patients who were not offered surgery as treatment (64%) with an APR of 2.1 (95% CI: 1. 2-3.8) . Note that patients with dementia also showed the second highest prevalence of stage IV, with 30% of the cases. However, patients with rheumatologic disease showed the highest prevalence of major surgery (91%) and also the highest APR for minor surgery (2.0; 95% CI: 1.0-3.7). Major surgery was the most common type of surgery among all CRC patients, with at least 90% for all comorbidities. The pattern of time to surgery by comorbidities showed considerable variability. Overall, among the majority of comorbidities, one-third of CRC patients were offered surgery 60 or more days after the cancer diagnosis.
However, dementia patients showed a different pattern: 30% had emergency surgery the same day as hospital admission (time to surgery of zero days). CRC with congestive heart failure showed the highest APR (1.7; 95% CI: 1.0-2.9) comparing surgery more than 60 days vs. emergency surgery (zero days) (Tables 2 and S2). Table 3 shows the risk factors associated with the presence of multimorbidity versus the absence of comorbidities by patients, tumor, and healthcare factors. Overall, a higher risk of multimorbidity was associated with being aged ≥ 75 years, obese, male, or current smoker ( Figure 3) . Likewise, being offered surgery more than 60 days after cancer diagnosis and not being offered surgery were associated with a higher risk of multimorbidity. It is important to highlight that 37% of patients having emergency surgery had multimorbidity and were aged ≥ 75 years.
Furthermore, 30% of emergency surgery was performed in older (≥75 years) advanced stage (III/IV) CRC patients affected by dementia. There was limited evidence supporting that patients with multimorbidity versus non-comorbidity had a 30% higher risk of not being offered surgery (RR 1.3; 95% CI: 0.9-2.1). However, we found strong evidence of surgery after 60 days in multimorbid CRC patients compared to patients with no comorbidity. Patients affected by multimorbidity had 2.4 times the risk of being offered late surgery compared to emergency surgery (0 days) (ARR: 2.4; 95% CI: 1.4-4.1) ( Table 3) . Furthermore, the complete visualization of CoMCoR study results is provided at the following link http://watzilei.com/shiny/CoMCoR/.
Discussion
Overall, comorbidity is commonly recognized as being associated with cancer outcomes and survival [21] . However, there is an international sparsity of population-based epidemiological studies describing the prevalence of comorbidities and associated risk factors among cancer patients [22] . CoMCoR study fills this gap, providing translational evidence regarding the pattern of the prevalence of comorbidities, multimorbidity, and associated risk factors among CRC patients in Spain. The pattern is mainly characterized by a higher prevalence of diabetes, advanced cancer stage, and late surgery or no surgical treatment in older patients with dementia.
To the best of our knowledge, the CoMCoR study presented here is the first to identify the most prevalent comorbidities and associated risk factors among CRC patients in Spain, and characterize a particular pattern in the distribution and frequency of comorbidities and multimorbidity. While clinical studies are representative of only a selected part of the population, CoMCoR is a high-resolution population-based observational study using cancer registration and hospital medical records that translates its results into clinical practice based on real-world data.
Regarding the prevalence of comorbidities, we found that diabetes is the most prevalent comorbidity among CRC patients (24%). Among non-cancer populations, the prevalence of any 1 9 type of diabetes in adults in Spain has been reported to range between 6 and 11% [23] . However, there is a scarcity of literature reporting the prevalence of diabetes among CRC patients [22] .
Our findings were similar to those previously reported in a Taiwanese cohort of 1,197 CRC patients where 24% had either a reported history of diabetes or were currently taking one or more diabetes-controlling medications [24] . Some evidence shows that diabetes is associated with higher incidence of CRC and shorter CRC survival [25] . Thus, we argue that public health programs targeting cancer prevention strategies among diabetic patients might have a positive impact on CRC outcomes in Spain.
Furthermore, we found a high prevalence of advanced stage cancer diagnosis (stage III/IV) among all CRC patients, which was even higher in older CRC patients affected by dementia. We argue that this may be due to low utilization of CRC screening in Spain. In 2011, CRC screening programs were implemented in only nine Spanish regions, with just partial coverage [26] . While all populations would benefit from the systematic use of screening, socioeconomically disadvantaged groups, such as patients with dementia, may also benefit from a targeted CRC screening [27] .
Comorbid medical diseases are highly prevalent among elderly. Overall, over 60% of all cases of cancer are diagnosed after age 65 years, with 67% of cancer deaths occurring in this age group [28] . We found a high prevalence of older patients not being offered surgical treatment, but it was even higher for older patients with stage III/IV CRC and dementia. There are many reasons why cancer occurs more frequently in older persons. The elderly have less resistance and longer exposure to carcinogens, a decline in immune system functioning, an alteration in anti-0 2 0 tumor defenses, decreased DNA repair, defects in tumor-suppressor genes, and differences in biological behavior, including angiogenesis. These factors contribute to the elderly population often being affected by comorbidities which affect cancer diagnosis, treatment, and survival [29] .
The high prevalence we found of older CRC patients not being offered surgical treatment in stages III and IV partially it might reflect the low uptake and partial coverage of CRC screening and preventive strategies in Spain.
Regarding multimorbidity, we found that it is associated with late surgery (≥60 days after cancer diagnosis) and emergency surgery offered the same day of an emergency hospital admission. Recently published evidence has shown that CRC diagnosed after a hospital emergency room admission were more likely associated with older and more socioeconomically deprived individuals [30] . Although disease stage at the time of diagnosis of CRC is a crucial determinant of patient outcome, comorbidity increases the complexity of cancer management and affects survival duration. Cancer control and treatment research questions should address multimorbidity, particularly in the elderly [31] . Regarding the evidence examining time from cancer diagnosis to surgical treatment there is no conclusive evidence supporting an optimal window of time. However, a study from the American College of Surgeons has found that patients who had a cancer operation at precisely eight weeks (56 days) after the end of combined chemoradiotherapy had the best overall survival and successful removal of their residual tumors [32] . Other study found that CRC patients waiting longer than 12 weeks (84 days) to receive surgery had increased all-cause mortality compared with patients receiving surgery within four weeks (28 days) [33] . In a study of patients receiving elective surgery for colonic resection 1 2 1 following diagnosis with CRC in Ontario, it was found that factors influencing receipt of treatment after 42 days from diagnosis included older age and comorbidity [34] .
Emergency surgery was defined as surgery offered the same day of an emergency hospital admission. Thus, we were assuming implicitly that CRC was diagnosed as a consequence of an emergency surgical intervention. However, we do not have empirical data to support our assumption. On the other hand, 30% of emergency surgery was performed among older advanced-stage CRC patients with dementia. It has been shown that CRC diagnosed after a hospital emergency admission is more likely associated with older and more deprived individuals [35, 36] . Recently, a study showed that 18% of CRC cases that were diagnosed as emergency cases had "red flag" symptoms, indicating the disease could have been identified earlier [30] .
The promotion of CRC symptom awareness among the elderly might help them to early identify these symptoms and visit their general practitioner, who must refer them through the normal pathways to specialist evaluation [30] .
There have been attempts to reanalyze the different comorbidity scores and their weighting algorithms, which show that some diseases should have a higher weight (including dementia), and others a lower weight (including peptic ulcers). Different approaches to measuring comorbidity specifically in cancer patients include focusing on single comorbid conditions in isolation, or weighted indices such as the Charlson comorbidity index [37] , the Adult Comorbidity Evaluation -27 index (ACE-27) [38] , or the Elixhauser index [39] . However, to date, there is no agreed gold standard method upon which to measure comorbidity in the cancer patient population [40] . We used the Royal College of Surgeons system, which is a 2 2 clinical score used to evaluate the risk of death during surgery. The score applies an equal weight system to 12 different comorbidities categorized into 0, 1, 2 or more comorbidities, making it easy-to-use, since all comorbidities are considered equally important [18] .
We assumed that missing data were completely at random and performed a complete case analysis, which might introduce bias if the data were actually missing at random. However, our
CoMCoR study was merely descriptive, and the percentage of missing data for the main outcome (comorbidities) was only 2%. Also, we would like to acknowledge the limited scope of the analysis in terms of time and space, with only one calendar year of CRC incident cases and two population-based cancer registries, thus limiting the external validity of our findings and supporting the need of more studies.
In summary, the CoMCoR study has identified a consistent pattern in the distribution and frequency of comorbidities and multimorbidity for CRC patients in Spain, mostly associated with diabetes, dementia, advanced cancer diagnosis, older age, and surgical treatment. The high prevalence of CRC diagnosed at stage III/IV among elderly patients and patients with dementia and the high prevalence of older patients not being offered surgical treatment are significant findings that require immediate policy actions. Results from the CoMCoR study may help to foster CRC screening and preventive strategy policies in Spain and other countries. 
